Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited operates in Hospital, part of the Healthcare sector. It booked ₹7,615 cr of revenue in its latest quarter (Q2 FY27) and kept 8.3% of sales as profit. It is the largest of 9 Hospital companies we track, by market value.
From the company's consolidated segment filings (Ind AS 108). Margin is segment operating profit (before interest & tax) over segment revenue; reconciliation rows like inter-segment eliminations are excluded from the mix.
Healthier than 58% of companies in Healthcare, on all six measures of filed financials. Each measure is ranked against the 37–153 companies that reported it.
Measures financial condition, not whether to buy. Learn what this score means · How this is calculated
- RSI (14)
- 59
At close. Not part of the score.
How much profit it earns on the money it employs
How much it owes, and whether earnings cover the interest
Whether reported profit actually arrives as cash
Whether sales and profit have grown, and how steadily
What today's price implies, against our models or its peers
How much of the promoters' stake is pledged, and how much they hold
What if I invest in APOLLOHOSP?
Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.
The slider starts at 4%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.
P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-04.
An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.
| Revenue from Operations | ₹7,615 cr |
| Other Income | ₹45 cr |
| Total Income | ₹7,660 cr |
| Cost of Materials | ₹935 cr |
| Purchases of Stock-in-Trade | ₹3,059 cr |
| Inventory Change (±) | ₹-43 cr |
| Employee Benefit Expense | ₹873 cr |
| Finance Costs | ₹114 cr |
| Depreciation & Amortisation | ₹230 cr |
| Other Expenses | ₹1,599 cr |
| Total Expenses | ₹6,768 cr |
| Profit before Tax | ₹891 cr |
| Tax Expense | ₹245 cr |
| Share of JV / Associates | ₹12 cr |
| Net Profit | ₹660 cr |
| Net margin on total income | 8.6% |
| Metric | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|
| Revenue | 6,606 cr | 7,044 cr | 7,615 cr |
| Total income | 6,649 cr | 7,092 cr | 7,660 cr |
| Expenses | 5,938 cr | 6,307 cr | 6,768 cr |
| Profit before tax | 711 cr | 785 cr | 891 cr |
| Tax | 170 cr | 188 cr | 245 cr |
| Net profit (owners' share) | 529 cr | 581 cr | 630 cr |
| Net margin (owners' share, on revenue) | 8.0% | 8.2% | 8.3% |
| EPS (₹) | 36.82 | 40.39 | 43.74 |
| Company | Price | Market cap | P/E | ROE | Net margin | 1-yr return |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limitedthis company | ₹8,440 | ₹1.21 L cr | 52.2 | 24.5% | 8.2% | — |
| Max Healthcare Institute Limited | ₹896 | ₹87,160 cr | 52.6 | 14.6% | 16.2% | — |
| Manipal Health Enterprises Limited | ₹642 | ₹75,740 cr | 81.9 | — | 7.5% | — |
| Fortis Healthcare Limited | ₹786 | ₹59,306 cr | 55.6 | 10.8% | 10.5% | — |
| Narayana Hrudayalaya Ltd. | ₹1,871 | ₹38,228 cr | 31.6 | 24.1% | 10.6% | — |
| Global Health Limited | ₹1,326 | ₹35,621 cr | 40.4 | 20.3% | 14.9% | — |
| Aster DM Quality Care Limited | ₹681 | ₹35,303 cr | 549.5 | 1.4% | 1.2% | — |
| Krishna Institute of Medical Sciences Limited | ₹731 | ₹30,681 cr | 175.6 | 7.4% | 3.5% | — |
| Dr. Agarwal's Health Care Limited | ₹513 | ₹16,256 cr | 89.7 | 8.9% | 7.4% | — |
| Action | Detail | Ex-date |
|---|---|---|
| Dividend | ₹10 / share | 14 Aug 2026 |
| Dividend | ₹10 / share | 16 Feb 2026 |
| Dividend | ₹10 / share | 19 Aug 2025 |
| Dividend | ₹9 / share | 14 Feb 2025 |
| Dividend | ₹10 / share | 16 Aug 2024 |
| Dividend | ₹6 / share | 20 Feb 2024 |
A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.
Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.
Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.
Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.